Ryan Sullivan
Harvard University
H-index: 80
North America-United States
Top articles of Ryan Sullivan
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Plasma proteomics-based models for predicting therapeutic benefit and immune-related adverse events in non-small cell lung cancer patients treated with immunotherapy | Cancer Research | Michal Harel Petros Christopoulos Igor Puzanov Jair Bar Iris Kamer | 2024/3/22 |
Acute and chronic kidney function decline in patients receiving BRAF/MEK inhibitors for melanoma | Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association | Kavita Mistry Sophia Zhao Ian Strohbehn Qiyu Wang Paul Hanna | 2024/2/22 |
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product | bioRxiv | Avanish Mishra Shih-Bo Huang Taronish Dubash Risa Burr Ben S Wittner | 2024 |
Abstract CT183: Initial results from a phase 1a/1b study of STK-012, a first-in-class α/β IL-2 receptor biased partial agonist in advanced solid tumors (NCT05098132) | Cancer Research | Benjamin Izar Dmitriy Zamarin David R Spigel Christopher J Hoimes David F McDermott | 2024/4/5 |
Pilot Trial of an Educational Immunotherapy Intervention for Patients with Advanced Cancer | Laura A Petrillo Kelly Hsu Kedie Pintro Dustin Rabideau Ashley Zhou | 2023/11 | |
Dissecting tumor-immune interaction in response and resistance to immune checkpoint blockade in metastatic melanoma | Cancer Research | Giuseppe Tarantino Yiwen He Priyanka Solanky Aaron Thorner Tyler Aprati | 2024/3/22 |
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy | bioRxiv | Or-Yam Revach Angelina M Cicerchia Ofir Shorer Boryana Petrova Seth Anderson | 2024 |
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study | The Lancet | Jeffrey S Weber Matteo S Carlino Adnan Khattak Tarek Meniawy George Ansstas | 2024/2/17 |
Abstract CT030: Randomized placebo-controlled, biomarker-stratified phase 1b microbiome modulation trial for metastatic melanoma demonstrates impact of antibiotic pre … | Cancer Research | Isabella C Glitza Oliva Yongwoo David Seo Christine N Spencer Jennifer R Wortman Elizabeth M Burton | 2024/4/5 |
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort … | EClinicalMedicine | Xue Bai Ahmed Shaheen Charlotte Grieco Paolo D d’Arienzo Florentia Mina | 2023/11/1 |
Phase II study of cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma | Cancer Research | Meghan J Mooradian Florian J Fintelmann Thomas J LaSalle Judit Simon Alexander Graur | 2024/3/22 |
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator | Journal of Clinical Oncology | Alexander HR Varey Isabel Li Mary-Ann El Sharouni Julie Simon Aikaterini Dedeilia | 2024/2/5 |
Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma | JCO Precision Oncology | Takuto Sato Kamaneh Montazeri Evangelos S Gragoudas Anne Marie Lane Mary Beth Aronow | 2024/1 |
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity | Cancer Discovery | Isabella C Glitza Yongwoo David Seo Christine N Spencer Jennifer R Wortman Elizabeth M Burton | 2024/4/4 |
A phase II study of ERK inhibition by ulixertinib (BVD-523) in metastatic uveal melanoma | Elizabeth Iannotti Buchbinder Justine Vanessa Cohen Rizwan Haq F Stephen Hodi Donald P Lawrence | 2020/5/20 | |
What Is the Timing and Role of Targeted Therapy in Metastatic Melanoma? | Matthew J Hadfield Ryan J Sullivan | 2024/3/1 | |
Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: an international multicenter cohort study | JAAD International | Xue Bai Aleigha R Lawless Juliane A Czapla Stefanie C Gerstberger Benjamin C Park | 2024/1/19 |
Multicenter evaluation of radiation and immune checkpoint inhibitor therapy in mucosal melanoma and review of recent literature | Advances in Radiation Oncology | Alicia C Smart Anita Giobbie-Hurder Vineet Desai Jessica L Xing John N Lukens | 2024/1/1 |
How Much Data are Enough? Investigating Dataset Requirements for Patch-Based Brain MRI Segmentation Tasks | arXiv preprint arXiv:2404.03451 | Dongang Wang Peilin Liu Hengrui Wang Heidi Beadnall Kain Kyle | 2024/4/4 |
Improving multiple sclerosis lesion segmentation across clinical sites: A federated learning approach with noise-resilient training | Artificial Intelligence in Medicine | Lei Bai Dongang Wang Hengrui Wang Michael Barnett Mariano Cabezas | 2024/4/17 |
